Market Capitalization Reflects the total market ... Source: FactSet Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any ...
Neuren Pharmaceuticals' (ASX:NEU) stock is up by a considerable 13% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this ...
Jefferies analyst David Stanton maintained a Buy rating on Neuren Pharmaceuticals Limited (NURPF – Research Report) on January 17 and set a price target of A$32.75. The company’s shares closed ...
Market Index News on MSN3d
Morning Wrap: ASX 200 to fall, S&P 500 little changed + Nick Scali earningsNick Scali reported its 1H25 results, with a mixed bag of takeaways Let's dive in. Major US benchmarks finished mixed, with ...
Neuren Pharmaceuticals' (ASX:NEU) stock is up by a considerable 13% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback